BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

ErgoMed, Inc. 



San Antonio  Texas    U.S.A.
Phone: 800-333-ERGO Fax: 210-366-1075


SEARCH JOBS


Industry
Biotechnology






 Company News
Ferrer Internacional To Develop Lorediplon For Insomnia With Ildong Pharmaceuticals And ErgoMed Clinical Research 2/3/2014 9:04:16 AM    More...
CEL-SCI (CVM) and ErgoMed Sign Co-Development and Profit Sharing Agreement for Multikine in HIV/HPV Co-Infected Men and Women With Peri-Anal Warts 10/29/2013 10:03:23 AM    More...
CEL-SCI (CVM) and ErgoMed Sign Co-Development and Profit Sharing Agreement for Multikine In HIV/HPV Co-Infected Women With Cervical Dysplasia 10/15/2013 9:56:03 AM    More...
AEterna Zentaris (AEZS) and ErgoMed Sign Co-Development and Profit Sharing Agreement for AEZS-108 in Endometrial Cancer 4/10/2013 9:48:22 AM    More...
ErgoMed Signs Co-Development Collaboration Agreement With Genzyme Corporation (GENZ) to Develop Tasidotin in Oncology 5/6/2009 7:57:25 AM    More...
PAION And ErgoMed Report Full Data of CNS 5161 Phase IIa Study in Neuropathic Cancer Pain 4/9/2009 9:28:02 AM    More...
PAION And ErgoMed Complete Enrolment of Phase IIa Study with CNS 5161 in Opioid-Refractory Cancer Pain 12/22/2008 8:48:08 AM    More...
ErgoMed Locates Regional Headquarters at DuBiotech in Dubai 10/30/2007 11:30:33 AM    More...
ErgoMed Opens New Facility in Russia 10/22/2007 10:50:39 AM    More...
ErgoMed Signs Co-Development Deal With CeNeS Pharmaceuticals PLC (CEN.L) 7/13/2006 5:02:21 PM    More...
12

//-->